Andrew Gengos Athira Pharma, Inc. (ATHA) insider trading activity

ATHA Quotes by TradingView

Andrew Gengos is CFO AND CHIEF BUSINESS OFFICER of Athira Pharma, Inc.. Currently has a direct ownership of 80,012 shares of ATHA, which is worth approximately $259,238. The most recent transaction as insider was on Jun 07, 2023, when has been sold 15,000 shares (Common Stock) at a price of $3.4 per share, resulting in proceeds of $51,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 80K
0% 3M change
0% 12M change
Total Value Held $259,238

Andrew Gengos Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 07 2023
BUY
Open market or private purchase
$51,000 $3.4 p/Share
15,000 Added 15.79%
80,012 Common Stock
Jun 05 2023
BUY
Open market or private purchase
$135,450 $3.01 p/Share
45,000 Added 40.9%
65,012 Common Stock
Jun 02 2023
BUY
Open market or private purchase
$57,034 $2.85 p/Share
20,012 Added 50.0%
20,012 Common Stock
Jan 05 2023
SELL
Open market or private sale
$3,515 $2.91 p/Share
1,208 Reduced 1.42%
83,804 Common Stock
Jan 04 2023
BUY
Grant, award, or other acquisition
-
5,000 Added 5.55%
85,012 Common Stock

Also insider at

CYT
Cyteir Therapeutics, Inc. Healthcare
Chief Business Officer
AG

Andrew Gengos

CFO AND CHIEF BUSINESS OFFICER
Lexington, MA

Track Institutional and Insider Activities on ATHA

Follow Athira Pharma, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ATHA shares.

Notify only if

Insider Trading

Get notified when an Athira Pharma, Inc. insider buys or sells ATHA shares.

Notify only if

News

Receive news related to Athira Pharma, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ATHA